said intermediates, such as the nitrido in the distal pathway, and the diazene and hydrazine in the alternating pathway. Attempts to isolate the intermediates in nitrogenase itself have so far been unsuccessful, but the use of model complexes has allowed for the isolation of intermediates that support both sides depending on the metal center used. Studies with Mo generally point towards a distal pathway, while studies with Fe generally point towards an alternating pathway. Specific support for the distal pathway has mainly stemmed from the work of Schrock and Chatt, who successfully isolated the nitrido complex using Mo as the metal center in a model complex. Specific support for the alternating pathway stems from a few studies. Iron only model clusters have been shown to catalytically reduce N2. Small tungsten clusters have also been shown to follow an alternating pathway for nitrogen fixation. The vanadium nitrogenase releases hydrazine, an intermediate specific to the alternating mechanism. However, the lack of characterized intermediates in the native enzyme itself means that neither pathway has been definitively proven. Furthermore, computational studies have been found to support both sides, depending on whether the reaction site is assumed to be at Mo (distal) or at Fe (alternating) in the MoFe cofactor. Mechanism of MgATP binding Binding of MgATP is one of the central events to occur in the mechanism employed by nitrogenase. Hydrolysis of the terminal phosphate group of MgATP provides the energy needed to transfer electrons from the Fe protein to the MoFe protein. The binding interactions between the MgATP phosphate groups and the amino acid residues of the Fe protein are well understood by comparing to similar enzymes, while the interactions with the rest of the molecule are more elusive due to the lack of a Fe protein crystal structure with MgATP bound (as of 1996). Three protein residues have been shown to have significant interactions with the phosphates, shown in Figure 6. In the absence of MgATP, a salt bridge exists between residue 15, lysine, and residue 125, aspartic acid. Upon binding, this salt bridge is interrupted. Site-specific mutagenesis has demonstrated that when the lysine is substituted for a glutamine, the protein's affinity for MgATP is greatly reduced and when the lysine is substituted for an arginine, MgATP cannot bind due to the salt bridge being too strong. The necessity of specifically aspartic acid at site 125 has been shown through noting altered